主记录
Danirixin
- CAS
- 954126-98-8
- PubChem CID
- 24780598
- SMILES
- CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)[C@H]3CCCNC3)O
- 分子式
- C19H21ClFN3O4S
- 分子量
- 441.912
- 精确分子量
- 441.0925
- InChI
- InChI=1S/C19H21ClFN3O4S/c1-11-14(21)5-2-6-15(11)23-19(26)24-16-8-7-13(20)18(17(16)25)29(27,28)12-4-3-9-22-10-12/h2,5-8,12,22,25H,3-4,9-10H2,1H3,(H2,23,24,26)/t12-/m0/s1
- InChIKey
- NGYNBSHYFOFVLS-LBPRGKRZSA-N
- LogP
- 3.6628
- TPSA
- 107.53
名称与别名
- Danirixin
- Danirixina
- Danirixine
- danirixinum
- 954126-98-8
- GSK1325756
- GSK-1325756B
- Danirixin [USAN:INN]
- R318PGH5VP
- DANIRIXIN [INN]
- UNII-R318PGH5VP
- Danirixin (USAN/INN)
- DANIRIXIN [USAN]
- RefChem:585166
- GSK1325756B
- D0R7XD
- DANIRIXIN [WHO-DD]
- C19H21ClFN3O4S
- Danirixin (GSK1325756)
- GTPL8500
- orb1302008
- SCHEMBL1198688
- CHEMBL3039531
- SCHEMBL29815122
- Danirixin (GSK1325756)?
- MFCD27987922
- GLXC-15693
- EX-A1178
- GSK 1325756
- BDBM50633395